Tibetan Medical Interpretation of Myelin Lipids and Multiple Sclerosis
Author:
Publisher
Wiley
Subject
History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Reference109 articles.
1. Disease modifying therapies in multiple sclerosis; Subcommittee of the American Academy of neurology and the MS council for clinical practice guidelines;Goodin;Neurology,2002
2. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial;Paty;Neurology,1993
3. Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years;IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group;Neurology,1996
4. Copolymer 1: a most reasonable alternative therapy for early relapsing-remitting multiple sclerosis with mild disability;Wolinsky;Neurology,1995
5. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group;Johnson;Neurology,1995
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tibetan medicine Duoxuekang ameliorates hypobaric hypoxia-induced brain injury in mice by restoration of cerebrovascular function;Journal of Ethnopharmacology;2021-04
2. Longzhibu disease and its therapeutic effects by traditional Tibetan medicine: Ershi-wei Chenxiang pills;Journal of Ethnopharmacology;2020-03
3. Tibetan Medical informatics: An emerging field in Sowa Rigpa pharmacological & clinical research;Journal of Ethnopharmacology;2020-03
4. The Modern Biomedical Conception of Cancer and Its Many Potential Correlates in the Tibetan Medical Tradition;Knowledge and Context in Tibetan Medicine;2019-05-30
5. The path towards validating Tibetan and Chinese medicine by the food and drug administration;International Journal of Complementary & Alternative Medicine;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3